DrugPatentWatch
DrugPatentWatch provides authoritative biopharmaceutical intelligence, updated daily, transforming data into market insights for businesses in over 70 countries. They offer a subscription-based SaaS model with tiered plans (Starter, Professional, Enterprise) providing access to global drug patent information, litigation histories, generic drug manufacturer data, and alerts on patent expirations. The platform aids in identifying commercial opportunities, forecasting drug pipelines, analyzing competition, and refining market-entry strategies. Key features include a Deep Research Engine for business intelligence and AI-powered research assistance. DrugPatentWatch is developed by Yali Friedman, Ph.D., who is recognized for his contributions to biotechnology and has been cited by major publications like CNN and Nature Journals.
DrugPatentWatch
DrugPatentWatch provides authoritative biopharmaceutical intelligence, updated daily, transforming data into market insights for businesses in over 70 countries. They offer a subscription-based SaaS model with tiered plans (Starter, Professional, Enterprise) providing access to global drug patent information, litigation histories, generic drug manufacturer data, and alerts on patent expirations. The platform aids in identifying commercial opportunities, forecasting drug pipelines, analyzing competition, and refining market-entry strategies. Key features include a Deep Research Engine for business intelligence and AI-powered research assistance. DrugPatentWatch is developed by Yali Friedman, Ph.D., who is recognized for his contributions to biotechnology and has been cited by major publications like CNN and Nature Journals.